Prenatal Iron Supplements: Safety & Efficacy in Tanzania

产前铁补充剂：安全性

• 批准号: 7932836
• 负责人: Wafaie W Fawzi
• 金额: $ 19.95万
• 依托单位: HARVARD SCHOOL OF PUBLIC HEALTH
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-15 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7932836
• 关键词: Address; Adverse effects; Africa South of the Sahara; Allied Health Sciences; Anemia; Area; Biochemical; Birth Weight; Boston; Child; Clinic Visits; Collaborations; Communicable Diseases; Country; Enrollment; Ferritin; Ferrous Sulfate; Hemoglobin; High Prevalence; Incidence; Infant; Infection; Iron; Low Birth Weight Infant; Malaria; Measures; Parasites; Participant; Placebos; Plasma; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnant Women; Public Health; Public Health Schools; Randomized; Randomized Clinical Trials; Research; Review Literature; Risk; Safety; Serum; Supplementation; Tanzania; Universities; Woman; density; follow-up; milligram; pill; pregnant; prenatal; public health relevance; standard of care

DESCRIPTION (provided by applicant): Anemia is common in pregnancy, and increases the risks of adverse pregnancy outcomes including low birth weight. Iron deficiency is a leading cause of anemia in sub-Saharan Africa, and routine iron supplementation has become the standard of care during pregnancy in many countries. However, findings from recent trials among children have raised concerns regarding the safety of iron supplementation in malaria-endemic regions. After a thorough review of the literature, there is limited evidence on the safety and efficacy of prenatal iron supplementation, especially in areas of high malaria burden and among women who are not anemic. In order to address this important research gap, we propose a randomized clinical trial among 1,500 pregnant women in Tanzania. Participants will be randomized to receive 60 milligrams of ferrous sulphate or placebo daily, and will be followed up through the postpartum period. Women who are anemic (defined in Tanzania as Hb<8.5) or iron deficient (ferritin<12 pg/L) will receive iron, as per standard of care, and will not be enrolled in the trial. The primary aims are to determine the safety and efficacy of iron supplementation among pregnant Tanzanian women, as measured by the incidence and density of placental malaria infection, and maternal hemoglobin concentrations and infant birth weight, compared to placebo. Secondary aims are to examine the efficacy of iron supplements on the incidence of maternal anemia, low birth weight, and maternal malaria infection, compared to placebo. Compliance with supplement use will be assessed by direct questioning of women and pill count at monthly clinic visits. Biochemical assessment of compliance will also be assessed measuring the plasma concentration of serum ferritin in a random subsample of 300 women at randomization and at delivery. The study will be conducted as part of a collaboration between the Harvard School of Public Health in Boston, and Muhimbili University of Health and Allied Sciences in Dar es Salaam, Tanzania. PUBLIC HEALTH RELEVANCE: In sub-Saharan Africa, pregnant women are susceptible to anemia and its adverse effects. Any adverse effects of supplemental iron would be of considerable public health importance in malaria-endemic regions of sub-Saharan Africa, due to the high prevalence of iron deficiency and infectious diseases, and the large number of iron supplements that are routinely distributed.

描述（由申请人提供）：贫血在妊娠期很常见，会增加不良妊娠结局（包括低出生体重）的风险。缺铁是撒哈拉以南非洲贫血的主要原因，在许多国家，常规补铁已成为怀孕期间的护理标准。然而，最近在儿童中进行的试验结果引起了人们对疟疾流行地区补铁安全性的担忧。在对文献进行全面审查后，关于产前补铁的安全性和有效性的证据有限，特别是在疟疾负担高的地区和没有贫血的妇女中。为了解决这一重要的研究差距，我们提议在坦桑尼亚的1，500名孕妇中进行一项随机临床试验。参与者将被随机分配每天接受60毫克硫酸亚铁或安慰剂，并将在产后期间进行随访。贫血（在坦桑尼亚定义为Hb<8.5）或缺铁（铁蛋白<12 pg/L）的女性将按照标准治疗接受铁治疗，并且不会入选试验。主要目的是确定坦桑尼亚孕妇补铁的安全性和有效性，通过与安慰剂相比，胎盘疟疾感染的发病率和密度，以及母体血红蛋白浓度和婴儿出生体重来衡量。次要目的是检查与安慰剂相比，铁补充剂对孕产妇贫血、低出生体重和孕产妇疟疾感染发生率的疗效。通过直接询问妇女和每月门诊访视时的药丸计数来评估补充剂使用的依从性。还将通过测量随机分组和分娩时300名女性的随机子样本中血清铁蛋白的血浆浓度来评估依从性的生化评估。这项研究将作为波士顿哈佛公共卫生学院和坦桑尼亚达累斯萨拉姆Muhimbili健康与联合科学大学合作的一部分进行。 公共卫生相关性：在撒哈拉以南非洲，孕妇易患贫血及其不良影响。在撒哈拉以南非洲的疟疾流行地区，由于缺铁和传染病的高患病率以及常规分发的大量铁补充剂，补充铁的任何不利影响都具有相当大的公共卫生重要性。